The reductase steps of the type II fatty acid synthase as antimicrobial targets.
The increasing of multidrug resistance of clinically important pathogens calls for the development of novel antibiotics with unexploited cellular targets. FA biosynthesis in bacteria is catalyzed by a group of highly conserved proteins known as the type II FA synthase (FAS II) system. Bacterial FAS II organization is distinct from its mammalian counterpart; thus the FAS II pathway offers several unique steps for selective inhibition by antibacterial agents. Some known antibiotics that target the FAS II system include triclosan, isoniazid, and thiolactomycin. Recent years have seen remarkable progress in the understanding of the genetics, biochemistry, and regulation of the FAS II system with the availability of the complete genome sequence for many bacteria. Crystal structures of the FAS II pathway enzymes have been determined for not only the Escherichia coli model system but also other gram-negative and gram-positive pathogens. The protein structures have greatly facilitated structure-based design of novel inhibitors and the improvement of existing antibacterial agents. This review discusses new developments in the discovery of inhibitors that specifically target the two reductase steps of the FAS II system, beta-ketoacyl-acyl carrier potein (ACP) reductase and enoyl-ACP reductase.
Zhang
Yong-Mei
YM
Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
Lu
Ying-Jie
YJ
Rock
Charles O
CO
D000900:Anti-Bacterial Agents / Q000737:chemistry / Q000494:pharmacology*; D002384:Catalysis / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000737:chemistry / Q000494:pharmacology*; D064429:Fatty Acid Synthases / Q000037:antagonists & inhibitors* / Q000145:classification / Q000378:metabolism*; D006801:Humans; D010088:Oxidoreductases / Q000037:antagonists & inhibitors* / Q000378:metabolism*
D000900:Anti-Bacterial Agents; D004791:Enzyme Inhibitors; D010088:Oxidoreductases; D064429:Fatty Acid Synthases
Bioorg Med Chem Lett. 2001 Sep 3;11(17):2241-4
11527706
Antimicrob Agents Chemother. 2002 Oct;46(10):3118-24
12234833
Structure. 2004 Mar;12(3):417-28
15016358
Nature. 2000 Jul 13;406(6792):145-6
10910344
Antimicrob Agents Chemother. 2003 Jan;47(1):297-301
12499205
J Mol Biol. 2002 Jul 5;320(2):249-61
12079383
Antimicrob Agents Chemother. 2002 Nov;46(11):3343-7
12384334
J Biol Chem. 1999 Apr 16;274(16):11110-4
10196195
Biochim Biophys Acta. 1996 Jul 12;1302(1):1-16
8695652
J Med Chem. 2004 Jan 29;47(3):509-18
14736233
Bioorg Med Chem Lett. 2001 Aug 20;11(16):2061-5
11514139
Biochem Biophys Res Commun. 2001 Dec 14;289(4):832-7
11735121
Annu Rev Microbiol. 2001;55:305-32
11544358
Biochemistry. 2001 Oct 30;40(43):12772-81
11669613
J Biol Chem. 2003 Jun 6;278(23):20851-9
12606558
J Bacteriol. 2004 Mar;186(6):1869-78
14996818
Science. 1995 Mar 17;267(5204):1638-41
7886450
J Mol Biol. 1999 Jul 23;290(4):859-65
10398587
Science. 1994 Jan 14;263(5144):227-30
8284673
Biochemistry. 2003 Apr 22;42(15):4406-13
12693936
Biochem J. 2003 Mar 15;370(Pt 3):1055-62
12487627
J Bacteriol. 1989 Dec;171(12):6555-65
2687243
J Biol Chem. 1995 Nov 3;270(44):26538-42
7592873
J Biol Chem. 2000 Jan 28;275(4):2520-6
10644708
Antimicrob Agents Chemother. 2004 Jan;48(1):242-9
14693546
J Bacteriol. 1996 Jun;178(12):3614-20
8655562
Nat Med. 2001 Feb;7(2):167-73
11175846
J Biol Chem. 2004 Jul 23;279(30):30994-1001
15133034
Biochem Biophys Res Commun. 2002 Apr 19;292(5):1155-66
11969206
J Biol Chem. 2000 Feb 18;275(7):4654-9
10671494
FEBS Lett. 2000 Nov 3;484(2):65-8
11068033
Curr Opin Investig Drugs. 2004 Feb;5(2):146-53
15043388
Prog Lipid Res. 2001 Nov;40(6):467-97
11591436
J Biol Chem. 2000 Dec 22;275(51):40128-33
11007778
J Biol Chem. 2002 Apr 12;277(15):13106-14
11792710
J Biol Chem. 1998 Nov 13;273(46):30316-20
9804793
Biochim Biophys Acta. 1992 Apr 8;1120(2):151-9
1562581
J Med Chem. 2002 Jul 18;45(15):3246-56
12109908
Antimicrob Agents Chemother. 1999 Mar;43(3):711-3
10049298
Microbiology. 1998 Oct;144 ( Pt 10):2697-704
9802011
Science. 1998 Jan 2;279(5347):98-102
9417034
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):13881-6
14623976
J Med Chem. 2003 Apr 24;46(9):1627-35
12699381
Nature. 1998 Aug 6;394(6693):531-2
9707111
J Antibiot (Tokyo). 1984 Nov;37(11):1456-61
6511668
Science. 2003 Jan 31;299(5607):705-8
12560551